Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Other Non-Current Assets: 2021-2025

Historic Other Non-Current Assets for Prime Medicine (PRME) over the last 4 years, with Sep 2025 value amounting to $13.7 million.

  • Prime Medicine's Other Non-Current Assets fell 2.64% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year decrease of 2.64%. This contributed to the annual value of $14.1 million for FY2024, which is 4.19% up from last year.
  • Prime Medicine's Other Non-Current Assets amounted to $13.7 million in Q3 2025, which was down 0.00% from $13.7 million recorded in Q2 2025.
  • In the past 5 years, Prime Medicine's Other Non-Current Assets ranged from a high of $14.1 million in Q3 2024 and a low of $13.1 million during Q4 2021.
  • Its 3-year average for Other Non-Current Assets is $13.7 million, with a median of $13.5 million in 2024.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first climbed by 4.19% in 2024, then decreased by 2.64% in 2025.
  • Over the past 5 years, Prime Medicine's Other Non-Current Assets (Quarterly) stood at $13.1 million in 2021, then climbed by 2.83% to $13.5 million in 2022, then remained steady at $13.5 million in 2023, then grew by 4.19% to $14.1 million in 2024, then fell by 2.64% to $13.7 million in 2025.
  • Its Other Non-Current Assets stands at $13.7 million for Q3 2025, versus $13.7 million for Q2 2025 and $14.1 million for Q1 2025.